UB Spinoff Cytocybernetics Awarded Funding From NIH

Updated January 31, 2018 This content is archived.

News articles report that Cytocybernetics, a UB spinoff co-founded by two Jacobs School of Medicine and Biomedical Sciences faculty, has been awarded $1.5 million by the National Institutes of Health (NIH), which will support hiring and development. The company was founded by Glenna C. Bett, PhD, vice chair for research and associate professor of obstetrics and gynecology, and Randall L. Rasmusson, PhD, professor of physiology and biophysics.